Showing results (41-50 of 77) with videos related to
Sort By:
Pageof 8
Infection and Immunity|August 1, 1982
Immunoglobulin M and G antibody responses and persistence of these antibodies in adults after vaccination with a combined meningococcal group A and group C polysaccharide vaccineE C Beuvery, A B Leussink, R W Van Delft, et al.Scandinavian Journal of Infectious Diseases|January 1, 1994
Comparison of enhanced potency inactivated poliovirus vaccine (EIPV) versus standard oral poliovirus vaccine (OPV) in Thai infantsS Simasathien, S Migasena, C Beuvery, et al.Biologicals : Journal of the International Association of Biological Standardization|March 1, 1997
A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccineD J Wood, A B Heath, G F Kersten, et al.Vaccine|March 1, 1987
O-polysaccharide-protein conjugates induce high levels of specific antibodies to Pseudomonas aeruginosa immunotype 3 lipopolysaccharideP A van de Wiel, M H Witvliet, D Evenberg, et al.Infection and Immunity|February 1, 1989
Accessibility of gonococcal and meningococcal surface antigens: immunogold labeling for quantitative electron microscopyM Pâques, J S Teppema, E C Beuvery, et al.Journal of Immunological Methods|December 15, 1991
An isotype-specific spot-ELISA for the enumeration of antibody-secreting hybridomas and the determination of isotype switch variantsJ M Coco-Martin, P Koolwijk, C A van der Velden-de Groot, et al.Biologicals : Journal of the International Association of Biological Standardization|November 5, 1997
Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic siteL A Sawyer, D Wood, M Ferguson, et al.The Journal of Infection|May 1, 1983
Vaccine potential of meningococcal group C polysaccharide-tetanus toxoid conjugateE C Beuvery, F Miedema, R W van Delft, et al.Cytotechnology|January 1, 1993
Cultivation of the hybridoma cell line MN12 in a homogeneous continuous culture system: effect of culture ageJ M Coco-Martin, D E Martens, T A van der Velden-de Groot, et al.Cytotechnology|February 24, 2012
Batch control system vaccines: BCSV : A new man machine interface for bioreactorsG Wieten, R C Dorresteijn, M C Philippi, et al.Pageof 8